tiprankstipranks
China Shineway Pharmaceutical Group Limited (HK:2877)
:2877
Hong Kong Market
2877
China Shineway Pharmaceutical Group Limited
RESEARCH TOOLSreports
Want to see HK:2877 full AI Analyst Report?

China Shineway Pharmaceutical Group Limited (2877) Financial Statements

0 Followers

China Shineway Pharmaceutical Group Limited Financial Overview

China Shineway Pharmaceutical Group Limited's market cap is currently HK$7.31B. The company's EPS TTM is HK$0.486; its P/E ratio is 6.31; and it has a dividend yield of 5.80%. China Shineway Pharmaceutical Group Limited is scheduled to report earnings on March 27, 2026, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 3.05B¥ 3.78B¥ 4.52B¥ 3.95B¥ 3.22B
Gross Profit¥ 2.21B¥ 2.83B¥ 3.39B¥ 2.94B¥ 2.41B
Operating Income¥ 664.41M¥ 842.60M¥ 975.53M¥ 713.58M¥ 534.37M
EBITDA¥ 733.46M¥ 1.00B¥ 1.42B¥ 1.10B¥ 903.74M
Net Income¥ 925.36M¥ 840.05M¥ 969.51M¥ 722.77M¥ 556.67M
Balance Sheet
Cash & Short-Term Investments¥ 7.57B¥ 6.49B¥ 5.91B¥ 5.05B¥ 4.21B
Total Assets¥ 10.78B¥ 10.04B¥ 9.57B¥ 8.23B¥ 7.20B
Total Debt¥ 335.05M¥ 346.53M¥ 301.33M¥ 7.44M¥ 14.91M
Net Debt¥ -6.86B¥ -5.79B¥ -5.59B¥ -5.02B¥ -4.19B
Total Liabilities¥ 2.72B¥ 2.57B¥ 2.54B¥ 1.85B¥ 1.30B
Stockholders' Equity¥ 8.07B¥ 7.47B¥ 7.03B¥ 6.38B¥ 5.90B
Cash Flow
Free Cash Flow¥ 974.13M¥ 823.02M¥ 788.31M¥ 980.21M¥ 609.52M
Operating Cash Flow¥ 1.17B¥ 963.13M¥ 932.63M¥ 1.11B¥ 703.15M
Investing Cash Flow¥ 222.03M¥ -272.11M¥ -49.54M¥ -45.42M¥ 395.01M
Financing Cash Flow¥ -375.01M¥ -392.48M¥ -26.74M¥ -250.04M¥ -828.93M
Currency in CNY

China Shineway Pharmaceutical Group Limited Earnings and Revenue History

Income Statement >

China Shineway Pharmaceutical Group Limited Debt to Assets

Balance Sheet >

China Shineway Pharmaceutical Group Limited Cash Flow

Cash Flow >

China Shineway Pharmaceutical Group Limited Forecast EPS vs Actual EPS

Earnings >